Proteogenomics identifies c-Met inhibition as a therapeutic strategy for BAP1-deficient clear cell renal cell carcinoma
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2024-11-01
|
| Series: | Molecular Biomedicine |
| Online Access: | https://doi.org/10.1186/s43556-024-00220-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|